Figure 4. (A) Distribution of plasma dmtDNA in the antibody-mediated rejection (ABMR) (n=10) and T cell-mediated rejection (TCMR) (n=8) groups. (B) The receiver operating characteristic curve indicating the different donor performance characteristics between patients with ABMR and non-ABMR. (C) The time point of diagnosis of ABMR and TCMR post-transplantation (months). (D) The time point of patients with ABMR was significantly higher than that in TCMR group.